Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Will Patient Deaths Derail Merck's New Cancer Drug?
Research & Development Will Patient Deaths Derail Merck's New Cancer Drug?

The cutting edge of cancer treatment often involves a delicate and high-stakes balance between revolutionary efficacy and severe, sometimes fatal, side effects. This reality has been starkly highlighted as a pivotal late-stage clinical trial for a promising new cancer therapy, ifinatamab deruxtecan

USD Med School Research Transforms South Dakota Health
Research & Development USD Med School Research Transforms South Dakota Health

In the quiet landscape of South Dakota, a veteran who had endured years of unrelenting chronic pain alongside the invisible wounds of post-traumatic stress disorder found an unexpected and complete reprieve, not from a new pill or surgical procedure, but from a low-level electrical current gently

Cheaper Health Plans Come With Hidden Risks
Research & Development Cheaper Health Plans Come With Hidden Risks

For millions of Americans navigating the annual health insurance marketplace, the stark reality of rising premiums forces a difficult calculation between financial solvency and physical well-being. This yearly ritual has become a high-stakes balancing act, where the allure of a lower monthly

Urinary MicroRNA Aging Clock – Review
Research & Development Urinary MicroRNA Aging Clock – Review

The longstanding quest to measure the true pace of human aging, independent of the calendar, has taken a decisive turn with the development of a biomarker that can be read from a simple urine sample. The development of the urinary microRNA (uEV-miRNA) aging clock represents a significant

Flow Chemistry, AI, and NMR Redefine API Production
Tech & Innovation Flow Chemistry, AI, and NMR Redefine API Production

At the forefront of pharmaceutical innovation, Ivan Kairatov is reimagining how essential medicines are made. As a leading expert in biopharma, his work merges the precision of continuous flow chemistry with the intelligence of advanced AI and real-time analytics. In a landscape reshaped by global

Blood Test Reveals Who Benefits From Colon Cancer Drug
Research & Development Blood Test Reveals Who Benefits From Colon Cancer Drug

For decades, oncologists have wrestled with a difficult paradox in treating colon cancer: a promising anti-inflammatory drug seemed to work for some patients but not for others, leaving doctors without a clear path forward until a re-examination of old evidence revealed a hidden clue in the

AI Smartwatch Cuts Child Tantrums in Half
Tech & Innovation AI Smartwatch Cuts Child Tantrums in Half

The crescendo of a child's emotional outburst often feels like an unpredictable storm, leaving parents feeling helpless and overwhelmed in its wake, but pioneering technology is now offering families a crucial tool to forecast these emotional tempests before they make landfall. Researchers have

Remote MRI Offers Greater Safety and Access
Tech & Innovation Remote MRI Offers Greater Safety and Access

The rapid expansion of remote technologies into medicine often raises valid concerns about the loss of the human touch, but a groundbreaking shift in Magnetic Resonance Imaging (MRI) is challenging this narrative by demonstrating how distance can paradoxically lead to a more focused, safer, and

How Zinc Starvation Disarms a Common Fungus
Research & Development How Zinc Starvation Disarms a Common Fungus

We're joined today by Ivan Kairatov, a leading biopharma expert whose work is at the forefront of understanding our complex relationship with the microscopic world inside us. His team's recent discoveries are reshaping how we view the common fungus Candida albicans —not just as a potential threat,

New Test Identifies Superbug Resistance and Virulence
Tech & Innovation New Test Identifies Superbug Resistance and Virulence

Within the sterile confines of a hospital, a microscopic battle is being waged where the enemy not only deflects our best weapons but also mounts a devastatingly aggressive counterattack. This escalating conflict against antibiotic-resistant bacteria has found a powerful new adversary in Klebsiella

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later